Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Everolimus-D4 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco E0701ML
Description
A stable-labeled internal standard for the immunosuppressant Everolimus, marketed as Zortress™ and Certican for use in organ transplantation and Afinitor™ for treatment of kidney and pancreatic cancers. Clinical laboratories quantitate everolimus levels in patient whole blood samples using LC-MS/MS. While many everolimus LC-MS/MS methods use 32-desmethoxyrapamycin or ascomycin as an internal standard, higher levels of variability / lower levels of reproducibility may occur in the analysis along with the potential for interferences. Use of a stable-labeled analog of everolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.
Specifications
| 75-05-8, 1338452-54-2 | |
| UN 1648 3 / PGII | |
| 962.25 | |
| 1 mL |
| C53H79NO14D4 | |
| 100 μg/mL in acetonitrile | |
| Ampule | |
| 2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
H312
EINECSNumber : 200-835-2
Recommended Storage : -70°C
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?Share a Content Correction